VCEL - Vericel CorporationAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $39.73 | Open | |
| Volume | Market Cap | 684.58M | |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| Vericel to Present at the 23rd Annual Ne... | 01/08/21 |
| CAMBRIDGE, Mass., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| The Daily Biotech Pulse: FDA Nod For Amp... | 12/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl... | |
| Vericel to Present at the 39th Annual J.... | 12/18/20 |
| CAMBRIDGE, Mass., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| The Daily Biotech Pulse: Pfizer-BioNTech... | 12/02/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbV... | |
| Cell Therapy Market With Leading Players... | 11/17/20 |
| Cell therapy (CT) is the process of transplanting human cells to replace or repair damaged tissue or cells. Various methods can be used to carry out c... | |
| The Daily Biotech Pulse: Setback For Alk... | 11/17/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Ali... | |
| H.C. Wainwright Stick to Their Buy Ratin... | 11/09/20 |
| H.C. Wainwright Stick to Their Buy Rating for Vericel Corp | |
| Vericel Reports Record Third Quarter Rev... | 11/05/20 |
| Total Net Revenues of $32.3 Million and Net Income of $3.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE... | |
| Sitting on a Cash Pile 7.0? Sports Bioph... | 11/03/20 |
| #cash #cell #buy #burn #sports #biopharma $VCEL Vericel Corp. (NASDAQ:VCEL) broke out on 4 September at 16.90, it has yet to confirm, so this an early... | |
| Vericel to Present at Upcoming Investor ... | 11/02/20 |
| CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| Outstanding Scope of Regenerative Medici... | 10/26/20 |
| Regenerative medicine is the piece of medicine that makes procedures to regrow, fix or supersede hurt or undesirable cells, organs or tissues. Regener... | |
| Vericel (NASDAQ:VCEL) Price Target Raise... | 10/22/20 |
| Vericel (NASDAQ:VCEL) had its target price boosted by BTIG Research from $23.00 to $30.00 in a research report sent to investors on Monday, The Fly re... | |
| Vericel Co. to Post Q1 2022 Earnings of ... | 10/22/20 |
| Vericel Co. (NASDAQ:VCEL) ??? Equities researchers at SVB Leerink issued their Q1 2022 earnings estimates for shares of Vericel in a research note iss... | |
| Vericel (NASDAQ:VCEL) PT Raised to $30.0... | 10/21/20 |
| Vericel (NASDAQ:VCEL) had its price objective increased by investment analysts at BTIG Research from $23.00 to $30.00 in a research note issued on Mon... | |
| The Daily Biotech Pulse: J&J Pauses Coro... | 10/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X... | |
| P/E Ratio Insights for Vericel | 10/12/20 |
| In the current session, Vericel Inc. (NASDAQ: VCEL) is trading at $21.92, after a 0.46% gain. Over the past month, the stock increased ??? | |
| The Daily Biotech Pulse: Bristol-Myers S... | 10/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ... | |
| The Daily Biotech Pulse: Pfizer, BioNTec... | 10/06/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X ... | |
| World Cell & Gene Therapy Markets, 2025 ... | 08/06/20 |
| DUBLIN--(BUSINESS WIRE)--The "Cell & Gene Therapy Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's of... | |
| Vericel (VCEL) Q2 2020 Earnings Call Tra... | 08/06/20 |
| VCEL earnings call for the period ending June 30, 2020. | |
| Vericel Reports Second Quarter 2020 Fina... | 08/05/20 |
| Product Revenues of $20.0 Million Reported for the Second Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE?... | |
| Vericel to Report Second-Quarter 2020 Fi... | 07/22/20 |
| CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and seve... | |
| Vericel Announces Preliminary Second Qua... | 07/09/20 |
| CAMBRIDGE, Mass., July 09, 2020 -- Vericel Corporation , a leader in advanced therapies for the sports medicine and severe burn care markets, today an... | |
| Vericel Announces Submission of Biologic... | 06/30/20 |
| CAMBRIDGE, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL) today announced the submission of a Biologics License Applicati... | |
| Zacks.com featured highlights include: M... | 05/27/20 |
| Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories | |
| Regenerative Medicine Industry Outlook t... | 05/14/20 |
| DUBLIN, May 14, 2020 /PRNewswire/ -- The "Global Regenerative Medicine Market By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Other... | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| Should You Buy Vericel (VCEL) Ahead of E... | 02/24/20 |
| Vericel (VCEL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | |
| Vericel Analyst Projects Wound Care Prod... | 10/09/19 |
| Vericel Corp (NASDAQ: VCEL ), a commercial-stage company that specializes in advanced cell therapies for treating patients with knee cartilage defects... | |
| Buy rating | 01/12/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $26.00 to $44.00 | |
| Strong Buy rating | 12/18/20 |
| Stephens & Co. initiates coverage with Overweight rating and announces Price Target of $31.00 | |
| Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | ($0.02)/ 31.06M |
| Actual (EPS/Rev.) | $0.08/ $32.26 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
